Homesickness-Going Home for the New Year
Release time:
2020-07-22
Homesickness-Home for the New Year
When I was a child, homesickness was a small stamp,
I was at this end and my mother was at that end.
When I grow up, homesickness is a narrow ticket.
I am at this end and the bride is at that end.
Later, homesickness is a short tomb,
I am outside and my mother is inside.
Now, homesickness is a shallow strait,
I am at this end and the mainland is at that end.
-Yu Guangzhong's "Homesickness"
Homesickness is a ticket in the eyes of many travelers, a ticket with a destination called "home. A ticket is the expectation of relatives. "If you have money but no money, go home for the New Year", whether you are a tourist from all over the world or a wanderer wandering overseas; whether you are a high-ranking official or a common person; whether you are a migrant worker on your way back home, or a public servant who is busy with affairs. No matter how hard the journey is, even if you wait in line all night to buy only one ticket without seats, even if you are flustered and blocked, "people are on the road" and "standing", you have to rush home. At the station, the crowd was surging and packed, and there were "homecoming" everywhere ". You can see everyone carrying big bags and small bags with smiles on their faces. This is the smile of going home, this is the smile of the New Year, and this is the smile of reunion with relatives. I also joined this army. When I got on the bus, I really felt that I was going home. When I get off the bus, I see everything in my hometown is so familiar and strange. When standing at the door of the house, the mood is perturbed and excited. When knocking on the door and looking at the parents' increasingly old face, increasingly rickety back, increasingly frosty sideburns, increasingly faltering footsteps, a bitter mood welled up in my heart. After work, I spend less and less time with my parents. Every time I call, I say everything is fine at home. Don't worry. The moment they saw me, they only said lightly: it is good to go home! But I know how much they want me to spend more time with them and talk with them.
Although the seven-day annual leave is very short, it is happy and sweet to be able to chat with parents, brothers and sisters and speak the truth. Going home for the New Year is a kind of belief, a call, and a kind of guidance. The emotion of going home for the New Year is an obsession that grows in the bones of the Chinese people and will never change. Going home for the New Year is the best gift for parents. Going home for the New Year is the biggest and most beautiful nostalgia! (Fang Yuyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page